Form 4 · MRK
Merck EVP&Pres Richard R. DeLuca reports selling 58,185 shares
Richard R. DeLuca, Merck's EVP&Pres, Merck Animal Heallth, filed a Form 4 on Nov 16, 2026 at 4:19 PM ET reporting transactions on Nov 12, 2026.
The filing reports 58,185 shares in an open-market or private sale (code S) at $148.01, about $8.6 million in total; and 58,185 shares in an exercise or conversion of a derivative security (code M).
The filing does not indicate that the sales were made under a Rule 10b5-1 trading plan.
After these transactions, the filing lists about 112,955 shares held directly.
Reporting person
- Richard R. DeLuca, EVP&Pres, Merck Animal Heallth (as filed: DeLuca Richard R.)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-12 | M | Common Stock | 58,185 | $77.62 | Acquired | 171,140 | Direct |
| 2026-11-12 | S | Common Stock | 58,185 | $148.01 | Disposed | 112,955 | Direct |
| 2026-11-12 | M | Stock Option (Right to Buy) (derivative) | 58,185 | Disposed | 0 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 16, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Merck company file → · More Merck filings
Disclosures
- Editor holdings in MRK
- The editor holds no position in Merck (MRK). As of Nov 11, 2026.
- Last updated
- Nov 16, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold MRK.